Kymanox · 1 day ago
Director, Commissioning, Qualification, and Validation
Kymanox is a life sciences professional services company dedicated to delivering high-quality solutions in the life sciences industry. The Director of Commissioning, Qualification, and Validation (CQV) is responsible for guiding technical and managerial aspects of CQV projects, managing a team, and driving business development initiatives to enhance Kymanox's market presence.
Life ScienceTechnical Support
Responsibilities
Deliver senior technical oversight to client-facing Kymanox project teams, ensuring accountability for project strategy, execution, and overall client satisfaction
Oversee the planning and implementation of CQV/CSV activities, delegating tasks while monitoring quality and progress, and providing necessary technical direction to project teams
Establish and cultivate strong relationships with clients, understanding their needs and expectations to deliver tailored CQV/CSV solutions
Proactively engage with prospective clients to identify new business opportunities and foster partnerships
Drive business growth by leveraging an extensive professional network within the pharmaceutical, biotech, and medical device sectors
Collaborate closely with Kymanox's Business Development and Marketing teams to develop strategic approaches for promoting CQV/CSV services and pursuing new market opportunities
Actively participate in industry conferences, seminars, and/or public speaking engagements to represent Kymanox and enhance its visibility, positioning the company as a thought leader in the CQV space
Foster mentorship and growth within the team, providing development opportunities through cross-functional projects and direct partnerships
Lead and manage team performance through regular evaluations, coaching, resource allocation, goal setting, and monitoring time tracking and reporting
Support internal initiatives aimed at enhancing Kymanox processes and practices, assessing future business needs and implementing strategies to meet those needs effectively
Ensure conformance with both Kymanox and external regulatory standards, conducting rigorous technical and quality reviews of all source documents
Author and/or review process documentation including user requirements, technical design specifications, risk management documents (including user FMEA), and verification and validation testing protocols, while identifying any regulatory risks during reviews
Provide expert knowledge across all CQV and CSV disciplines
Ability to travel up to 25% during active client engagements as required
Qualification
Required
Bachelor's and/or Master's degree in a science-related field (e.g., Biomedical Engineering, Mechanical Engineering, Chemical Engineering)
A minimum of 15 years of experience in pharmaceutical, vaccine, biotech/biologics, cell/gene therapy, and/or medical device sectors
At least 10 years in a leadership capacity, demonstrating an established track record of guiding high-performing teams
Direct experience executing CQV activities for facilities, utilities, equipment, and processes
Direct experience or in-depth knowledge of CSV activities for computerized systems supporting manufacturing operations (ERP, CMMS, QMS, BMS, EMS, etc.)
Strong working knowledge of cGMP (21 CFR 210/211, Part 11, EU Annex 1, EU Annex 11), ASTM E2500, GAMP 5, and ISPE guidelines
Ability to travel up to 25% during active client engagements as required
Preferred
Experience with automated equipment (formulation, filling lines, isolators, device assembly equipment, finish/packaging, clean utilities, etc.) strongly preferred
Familiarity with pre-filled syringes, autoinjectors, co-packaged kits, and other drug delivery systems is preferred
Benefits
Medical healthcare including dental and vision
Short- and long-term disability
Life insurance
Matching 401(k) retirement plan
Continuing education assistance
Other benefits
Company
Kymanox
Kymanox is a technical products & project management company provides engineering, scientific, regulatory, and process operations support.
Funding
Current Stage
Growth StageTotal Funding
unknown2021-08-23Debt Financing
2021-08-02Series Unknown
Recent News
EIN Presswire
2025-05-08
GlobeNewswire News Room
2024-11-29
Company data provided by crunchbase